Techedge AI | Latest AI & Technology News Today

Kahua Launches AI No-Code Builder for PMIS

Kahua Unveils AI-Powered kBuilder Canvas to Bring No-Code App Design to Construction PM Systems

PR NewswireFebruary 18, 2026February 18, 202605 mins

Construction tech has a customization problem. Every capital program is different, but most project management systems still force teams into rigid workflows—or into expensive, slow customization cycles. Now, Kahua wants to break that pattern. The asset-centric project management platform has announced kBuilder Canvas, an AI-assisted, no-code solution builder designed to let construction organizations configure and…

EPAM Launches Empathy Lab in North America to Help CMOs Rebuild Marketing for the AI Era

PR NewswireFebruary 18, 2026February 18, 202606 mins

As generative AI reshapes everything from search to shopping, EPAM Systems, Inc. is betting that marketing needs more than automation—it needs a structural overhaul. This week, the digital engineering firm announced the North American launch of Empathy Lab by EPAM, an AI-native agency designed to help brands re-architect marketing around intelligent, human-centered growth systems. The…

Carbon Promotes Polymer Pioneer Jason Rolland to CTO, Signaling Next Phase of Additive Manufacturing Innovation

PR NewswireFebruary 17, 2026February 17, 202605 mins

Additive manufacturing firm Carbon has promoted longtime executive and polymer scientist Jason Rolland, Ph.D., to Chief Technology Officer, elevating one of the company’s earliest hires to oversee its broader product development and R&D strategy. For Carbon, the move isn’t just a leadership reshuffle—it’s a signal that materials science and platform integration remain central to its…

Roche Achieves Superior Remission in Membranous Nephropathy

Roche’s Phase III MAJESTY Study Shows Gazyva®/Gazyvaro® Achieves Superior Remission in Primary Membranous Nephropathy

GlobeNewswireFebruary 17, 2026February 17, 202603 mins

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that its phase III MAJESTY study met its primary endpoint in adults with primary membranous nephropathy (PMN), demonstrating statistically significant and clinically meaningful results with Gazyva®/Gazyvaro® (obinutuzumab). At 104 weeks, significantly more patients treated with Gazyva/Gazyvaro achieved complete remission compared with those receiving tacrolimus. The safety profile was…

iFLYTEK to Showcase Secure, Deployable AI Solutions at MWC Barcelona 2026

GlobeNewswireFebruary 17, 2026February 17, 202603 mins

Global AI and speech technology leader iFLYTEK will present a suite of secure, real-world AI solutions at MWC Barcelona 2026, taking place March 2–5. The company’s showcase emphasizes practical deployment, data security, offline capabilities, and localized multilingual intelligence—moving beyond experimental AI concepts to enterprise-ready infrastructure and applications. Secure AI Infrastructure for Industrial Resilience At the…